The Centers for Medicare & Medicaid Services (CMS) operates the Quality Improvement Organization (QIO) Program to ensure and improve the quality of health care for Medicare beneficiaries. This report presents the results of an independent evaluation of the ninth scope of work, QIO Program,...

This study compares key patient outcomes at Brand New Day, a Medicare SNP for dual eligibles with severe mental illness, under two alternatives—routine care (services routinely provided at the plan before the study) and enhanced care (more frequent or more intensive services)—for...

The study findings suggest that only one of the interventions tested (more frequent routine contacts and medication review) appeared to have led to improved outcomes, but the lack of consistency of favorable findings across outcomes for this intervention, and the anomalous finding for the...

Presents findings from the third report to Congress on the Medicare Coordinated Care Demonstration.

This articles examines interim impacts of a disease management demonstration for Medicare fee-for-service beneficiaries also enrolled in Medicaid (dual eligibles). The study randomly assigned dual eligibles with congestive heart failure, coronary artery disease, and/or diabetes to treatment or...

Before Medicare Part D, Congress authorized the Medicare disease management demonstration to evaluate whether disease management programs—in conjunction with a comprehensive prescription drug benefit—could improve health outcomes and reduce Medicare expenditures. The demonstration...